Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check3 days agoChange DetectedThe study status on the page is updated to Completed and results are posted, including 6-month tumor response data (PR/SD/PD) and survival outcomes (DFS and OS). A PDF of the Study Protocol and Statistical Analysis Plan was added to the Study Documents.SummaryDifference3%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No changes to the trial details or visible content.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays 'Results Submitted' and removes the 'No Results Posted' message.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.2 was added and the funding-status notice and Revision: v3.4.1 were removed; these are administrative and do not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedNotice added at the top of the page informing users about a lapse in government funding and the NIH Clinical Center's operating status, and the page version updated from v3.4.0 to v3.4.1. These updates do not alter the study details, objectives, eligibility, outcomes, or schedules.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.